Pharma & healthcare investments surge 166% in July-Sept on back of big-ticket deals: Report

Pharma and biotech segment continued to dominate dealmaking, accounting for 26 per cent of overall deals, according to a Grant Thornton Bharat’s Pharma and Healthcare Dealtracker.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *